Drug intelligence / Profile preview

Exxenterol

Development stage
Unknown
Lead developer
Exxentia
Administration
Oral
01

Overview

Exxenterol is a plant-derived fiber extract developed by Exxentia Grupo Fitoterapéutico, S.A. (Spain), derived from the carob bean (*Ceratonia siliqua*). It is composed of approximately 90% insoluble fiber and 80% insoluble polyphenols. Classified as a phytotherapeutic or nutraceutical product, it is primarily indicated for the reduction of serum total and LDL cholesterol levels in adults with moderate hypercholesterolemia. The product's mechanism of action is attributed to the cholesterol-lowering properties of its insoluble dietary fiber and polyphenol content, which are believed to interfere with cholesterol absorption or metabolism. It has been evaluated in a Phase 2 dose-finding clinical trial in Spain to establish the optimal therapeutic dose for cholesterol reduction.

Brand names
Exxenterol
Other names
carob fiber extractinsoluble carob fiber

Beyond the preview

Go deeper on Exxenterol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exxenterol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call